The mission of CNICS is to provide access to the specimen and data repository to any investigator who submits an approved concept proposal. CNICS is a ‘peer-reviewed open access’ research platform available to investigators world-wide.
Upon submission of a concept study, the CNICS administration will check for overlapping ideas or aims with an existing CNICS study to ensure each study has a unique data set without conflict. Should a new study be submitted that includes overlap, the CNICS administration will work with researchers of both concepts to collaborate where research interests align. A searchable list of concept proposals is below. This list does not represent all studies in CNICS. Contact the Administrative Core for further information.
MAKING AN IMPACT: CNICS has reviewed over 300 concept studies to date, submitted by investigators at all levels, including graduate students, fellows, staff and faculty. These studies have resulted in over 570 peer reviewed manuscripts and $189.7M in external funding awards (as of Oct 2025) to investigators working in CNICS, the majority of which are early career faculty and trainees. Over the last 5 year period, 32% of concepts have been led by PIs from non-CNICS sites and 73% by ESI and trainees, including 14 predoctoral students and 27 postdoctoral fellows.
Concept Number Concept Study Titles Investigator(s) Name Institute Study Status
001 IImpact of HAART and Metabolic Complications on Myocardial Infarction and Survival among HIV-infected Patients Heidi Crane University of Washington (UW) Open
002 Incidence and Risk Factors for Triple Class Antiretroviral Regimen (ARV) Exposure and Failure in the CNICS Cohort Richard Haubrich University of California San Diego (UCSD) Open
003 Biological and behavioral correlates of ART adherence and depression across patients in the CNICS cohorts Steven Safren Fenway Open
004 The incidence and correlates of HIV superinfection before starting and after stopping antiretroviral therapy Davey Smith University of California San Diego (UCSD) Open
005 Viral Variation and the Development of Neutralizing Antibodies Nancy L. Haigwood University of Washington (UW) Closed
006 gd-T cell Impairment and AIDS-associated Cancers Richard Lopez University of Alabama at Birmingham (UAB) Closed
007 STI Burden and Behavioral Risks among HIV-infected Patients in Primary Care at CNICS collaborating sites Kenneth Mayer Fenway Closed
008 Genetic variation and drug-drug interactions in tenofovir induced nephrotoxicity Kathleen Giancomini University of California San Francisco (UCSF) Closed
009 Predictors of Severe Liver Enzyme Elevation and Immunologic Response to Initial HAART in Patients with HIV and Hepatitis Co-Infection Chad Achenbach Northwestern Open
010 Eligibility for Early Initiation of Highly Active Antiretroviral Therapy (HAART) to Decrease HIV Transmission Julie Dombrowski University of Washington (UW) Open
011 Durability and Effectiveness of First-line ARV Regimens in treatment-naïve Patients Initiating Therapy in a Clinical Practice Setting- Michael Mugavero University of Alabama at Birmingham (UAB) Open
012 Association of cellular immune function and phenotype with severe liver enzyme elevation (LEE) after Highly Active Antiretroviral Therapy (HAART) among HIV and viral hepatitis co-infected patients Chad Achenbach Northwestern Closed
013 Long-term virologic outcomes of HIV-infected patients coinfected with hepatitis B on tenofovir-containing HAART Nina Kim University of Washington (UW) Open
014 Prevalence and associations of unprotected sex and substance use in the CNICS cohort Matthew Mimiaga Fenway Open
015 Dynamic Assessment of Virologic Response and Mortality Among HIV-infected Patients Initiating Antiretroviral Therapy Michael Mugavero University of Alabama at Birmingham (UAB) Open
016 An Analysis of Renal Function Before and After the Initiation of Highly Antiretroviral Therapy (HAART) to Examine Correlates of Renal Function Preservation and Decline Robert Kalayjian Case Western Reserve University (CWRU) Open
017 HIV Pathogenesis and Immunity in Viremic Non-Progressors David Camerini University of California Irvine (UC Irvine) Open
018 The Predictors of HIV+ smokers and investigation of smoking recognition and intervention by providers in two HIV ambulatory clinics Karen Cropsey University of Alabama at Birmingham (UAB) Open
019 Molecular Epidemiology of HIV Transmission and Transmitted Resistance in Women and Minorities in the CNICS Cohort Jeannette Aldous University of California San Diego (UCSD) Open
020 HIV infection in Sickle Cell Disease Michael Lederman Case Western Reserve University (CWRU) Closed
021 Generalizing evidence from randomized clinical trials to target populations: the ACTG-320 trial Steve Cole University of North Carolina at Chapel Hill (UNC) Open
022 Comparison of plasma HIV RNA with CD4+ T cell count-based strategies for detection of first line treatment failure and initiation of regimen modification Maya Peterson University of California Berkeley Open
023 Measuring HIV transmission risk among HIV+ patients at CNICS sites Joseph Schumacher University of Alabama at Birmingham (UAB) Open
024 AIDS-defining and non-AIDS defining malignancies among the CFAR Network of Integrated Clinical Systems (CNICS) Michael Saag University of Alabama at Birmingham (UAB) Open
025 Effects of Hepatitis B co-infection on HIV Antiretroviral Therapy Response and Long-term Outcomes Sarah Radke University of North Carolina at Chapel Hill (UNC) Open
026 Heterogeneity in Cytokine Responses to HIV-1 Infection James Tang University of Alabama at Birmingham (UAB) Closed
027 Methods to migrate from the 9-item Patient Health Questionnaire (PHQ-9) to computerized adaptive administration of the Patient Reported Outcomes Measurement Information System (PROMIS) depression measur Heidi Crane University of Washington (UW) Closed
028 HIV Infection and Response to Initial Therapy for Type 2 Diabetes University of Pennsylvania (UPENN) Open
029 Contribution of enzyme (protease) and substrate (gag) mutations to protease inhibitor resistance David Looney University of California San Diego (UCSD) Open
030 Epidemiology and Outcomes of HIV-2 in the United States Geoffrey Gottlieb University of Washington (UW) Open
031 Adherence to Clinical Care and Survival among HIV-infected Patients Initiating Antiretroviral Therapy Michael Mugavero University of Alabama at Birmingham (UAB) Open
032 HIV in the Elderly: Evaluating Indoleamine 2,3 dioxygenase as a marker for disease status Stephanie Baer Medical College of Georgia Open
033 HIV-associated Obstructive Pulmonary Disease Examinations (HOPE): Risk, Exacerbations, and Outcomes Kristina Crothers University of Washington (UW) Closed
034 Prognosis of incidence and progression risk of AIDS-defining and non-AIDS-defining malignancies in HIV/AIDS patients Julia Krauchanka Duke University Open
035 Body morphology abnormalities and patient reported outcomes: depression, adherence, health-related quality of life, substance use, physical activity, and sexual risk behavior Heidi Crane University of Washington (UW) Open
036 Routine Laboratory Monitoring During Virologically Suppressive Combination Antiretroviral Therapy in the US Babafemi Taiwo Northwestern Open
037 Fine mapping of MHC susceptibility loci for AIDS-related non-Hodgkin lymphoma Brahim Aissani University of Alabama at Birmingham (UAB) Open
038 The Timing of Antiretroviral Initiation among ART Naïve HIV Infected patients in routine clinical practice Elvin Geng University of California San Francisco (UCSF) Open
039 Cross-walk between commonly used measures of anxiety in patients with HIV and the Patient Reported Outcomes Measurement Information System (PROMIS) anxiety measure Heidi Crane University of Washington (UW) Open
040 Determinants of Transmitted Drug Resistance (TDR) and Impact of “Test and Treat” Strategy on Transmission of Drug Resistance Among HIV-1 Infected Treatment-Naïve Patients: Influence of High Risk Behaviors as Determined by Patient Based Metrics (PBM) on TDR Prevalence and Modeled Probability of Transmission Vi Bowman University of California San Diego Closed
041 Systematic Characterization of High-Risk HPV Infection in Head and Neck Carcinoma in HIV+ Individuals Margaret Brandwein-Gensler University of Alabama at Birmingham Open
042 Durability of initial compared to subsequent HAART regimens Eric Sahloff University of Toledo Open
043 Comparing Results from Two Methods for Estimating the Optimal CD4 Threshold for Initiating Antiretroviral Therapy Bryan Shephard Vanderbilt University Open
044 Biological Determinants of Long-term Immune Reconstitution following Combination Antiretroviral Therapy (cART) Sharon Lewin Monash University Australia Open
045 BMI, Depression, and HIV Self-Care Behaviors among MSM Aaron Blashill Fenway Open
046 Impact of presenting clinical features and subsequent treatment on outcomes after non-CNS HIV-associated lymphoma in the CNICS cohort Satish Gopal University of North Carolina at Chapel Hill (UNC) Open
047 Time related factors of platelet count reduction in human immunodeficiency virus/HIV and Hepatitis C/HCV co-infected antiretroviral therapy/ARV Naiive patients Chris Delaney University of Florida Closed
048 Structural models for exposure effects in HIV progression cohorts Steve Cole University of North Carolina at Chapel Hill (UNC) Open
049 Effects of Combination Antiretroviral Therapy on Risk of Non-AIDS- defining Cancers Elizabeth Yanik University of North Carolina at Chapel Hill (UNC) Closed
050 The Causal Effect of Antidepressant Treatment on HIV Outcomes in the CNICS Multi-Site Observational Clinical Cohort: An Application of Marginal Structural Models Brian Pence Duke University Open
051 Risk Factors and microRNA Profiles of HIV Associated Lung Cancer Kristina Crothers and Lynn Schnapp University of Washington (UW) Open
052 Molecular epidemiology of HIV transmission networks between Rhode Island and Massachusetts Phillip Chan Brown University Open
053 Incidence and treatment of prostate cancer in HIV-infected men Ramona Bhatia Northwestern Open
054 Impact of Transitioning from HIV Clinical Trials to Routine Medical Care on Virologic and Immunologic Outcomes Baligh R. Yehia University of Pennsylvania (UPENN) Closed
055 Current practice of screening for incident HCV infection among HIV-infected individuals Benjamin Linas Boston Medical Center Open
056 Evaluating the Relationship between HIV Transmission Networks in the San Diego-Tijuana Cross-Border HIV Epidemic and the Rest of the United States and the Difference between Geographically Localized and Geographically different Transmission Networks Sanjay Mehta University of California San Diego (UCSD) Open
057 The Natural History of Malignancies Developing Among HIV Positive Individuals on Stable Antiretroviral Therapy Anna Coghill University of Washington (UW) Open
058 Endothelial Dysfunction, Antiretroviral Therapy, and Non-AIDS Defining Events in the CNICS Cohort Susan Graham University of Washington (UW) Open
059 When to switch cART: A comparison of switching strategies using observational data Lauren Cain Harvard University Open
060 Effects of Hepatitis C Co-infection on HIV Disease Progression and Long term Outcomes Jennifer Ling University of Washington (UW) Closed
061 Frailty in HIV-infected older adults Charles Kamen and Supriya Mohile University of Rochester Open
062 STI Screening and Determinants of Infection Among HIV-Infected Patients in Primary Care Kenneth Mayer Fenway Open
063 Diagnosis and Treatment of Depression in HIV/AIDS Primary Care: A Comparative Analysis of Latino and Non-Latino White Patients Oscar Beltran University of Texas at El Paso (UTEP) Open
064 Behavioral predictors of outcomes in HIV infected adolescents
Brian Zanoni Massachusetts General Hospital, Fenway Community Health Open
065 Optimal timing for starting cART in antiretroviral-naïve HIV-1–infected patients presenting with cryptococcal meningitis Jonathan Sterne University of Bristol Open
066 Plasma cell neoplasms in HIV infected people: a multi center case series
Eric Engels National Cancer Institute Closed
067 Molecular profiling of HIV-associated lymphoma occurring before and during antiretroviral therapy Satish Gopal University of North Carolina at Chapel Hill (UNC) Open
068 Alcohol Research Consortium in HIV – Epidemiological Research Arm (ARCH-ERA)
U01AA020793
Heidi Crane University of Washington (UW) Open
068b Alcohol Research Consortium in HIV: COVID Supplement Heidi Crane University of Washington (UW) Open
069 Comparative effectiveness of SSRIs and SGAs among patients aging with HIV Heidi Crane University of Washington (UW) Open
070 OMCICH: Optimal Multidisciplinary Care in the Clinical HIV Setting Michael Horberg Mid-Atlantic Kaiser Permanente Group Open
071 Factors that influence the response to Hepatitis A vaccine among HIV-infected individuals Heidi Crane University of Washington (UW) Open
072 Statins in HIV: Immune Reconstitution, Comorbid Events, and Survival Dan Drozd University of Washington (UW) Open
073 Epidemiology of Cerebrovascular Disease in CNICS David Tirschwell University of Washington (UW) Open
074 Race-specific association between CCR5 -2459G>A genotype and virologic response to HAART in the CNICS cohort Rajeev Mehlotra Case Western Reserve University (CWRU) Closed
075 Modeling the dynamic association of BMI and mortality in HIV positive adults Jianghua He University of Massachusetts (UMASS) Closed
076 Relationship of virologic suppression and control of cardiometabolic comorbidities in HIV-infected patients on antiretroviral therapy Greer Burkholder University of Alabama at Birmingham (UAB) Open
077 Incidence and treatment of anal cancer in HIV-infected individuals Candice McNeil Stanford University Open
078 Hepatitis C treatment uptake and predictors of HCV therapy among HIV-infected individuals in the era of direct-acting antiviral agents
Ed Cachay University of California San Diego (UCSD) Open
079 Sero-incidence of Herpes Simplex Virus Types 1 and 2 in HIV-infected persons receiving HIV-care Nicholas Van Wagoner University of Alabama at Birmingham (UAB) Closed
080 Circulating MicroRNAs in HIV-infected Patients with and without Coronary Artery Disease Venkata Narla and Priscilla Hsue University of California San Francisco Open
081 Understanding Patient Populations Receiving Antiretroviral Therapy: Observational Channeling Bias Study Michael Saag, Steve Cole and Andy Westfall University of Alabama at Birmingham (UAB) & University of North Carolina at Chapel Hill (UNC) Open
082 Assessment of Markers of Microbial Translocation, Gut Mucosal Integrity, and Inflammation in HIV-infected Patients with Delayed Vs. Normal Immune Recovery on Suppressive Antiretroviral Therapy Gregory Huhn, Peter Hunt and Bellur Prabhakar Chicago Cook County Hospital Open
083 Effectiveness of Antiretroviral Therapy (ART) with Upfront Chemotherapy versus ART Alone in HIV-Infected Patients with Kaposi’s Sarcoma Who Do Not Have Urgent Indications for Chemotherapy
Jackie Wang University of California San Francisco (UCSF) Closed
084 Selection bias due to restriction in cohort studies Chanelle Howe Brown University Open
085 Antiretroviral switches in HIV/HCV co-infected patients: Initiating direct acting antiviral therapies for Hepatitis C Infection
Julius Wilder and Susanna Naggie Duke University Open
087 When to monitor: A comparison of immunologic and virologic monitoring strategies using observational data Ellen Caniglia Harvard University Open
088 Differential Virologic and Resistance Outcomes when using
Efavirenz-based Single Tablet Regimens versus Multiple Tablet
Regimens in HIV Treatments Michael Saag and Andy Westfall University of Alabama at Birmingham (UAB) Open
089 Calcium antagonist and CVD risk among hypertensive HIV+ patients Sadeep Shrestha University of Alabama at Birmingham (UAB) Closed
090 Identify and Manage Promptly Incident Hepatitis C: Testing to Treatment in HIV (IMPACT-C)
Benjamin Linas and Lynn Taylor Boston Medical Center Closed
091 Preventive fractions of Kaposi sarcoma and non-Hodgkin lymphoma in the modern ART era Elizabeth Yanik National Cancer Instittute Open
092 Application of the Updated ACC/AHA Atherosclerotic CVD Risk Assessment Tool and Prevention Guidelines Among HIV-Infected Individuals: CFAR Network of Integrated Clinical Systems (CNICS) Matthew Feinstein Northwestern Open
092a Performance of the American Heart Association’s PREVENT Risk Calculator for People with HIV Matt Durstenfeld University of California San Francisco (UCSF) Open
093 Analysis of CNICS data to inform design of interventions to enhance HIV care among substance abusers Bryan Hartzler University of Washington (UW) Open
094 Population interventions on smoking in the CNICS/ Bryan Hartzler UW Bryan Hartzler University of Washington (UW) Open
095 Factors Associated with HAART Medication Adherence among Older Adults Living with HIV in the U.S. Brian Witt University of North Carolina at Chapel Hill (UNC) Closed
096 The Affordable Care Act, Socioeconomic Context, Spatial Mapping, and Outcomes Among People Living With HIV Aadaora Adimora University of North Carolina at Chapel Hill (UNC) Open
097 Pathways contributing to racial and economic disparities among HIV clinic cohort patients Chanelle Brown Brown University Closed
098 Genomic approaches to cardiometabolic risk and treatment in HIV Inga Peter Mount Sinai Open
099 Investigating the relationship between chronic pain and HIV outcomes Jessie Merlin University of Alabama at Birmingham (UAB) Open
100 Cardiovascular, pulmonary, and hematological disease in HIV: Prevention and Treatment Heidi Crane University of Washington (UW) Open
101 Statin use among HIV-infected patients Greer Burkholder University of Alabama at Birmingham (UAB) Open
102 Comparative Effectiveness of Single-Action verses Multi-Action Antidepressants on Depression, Treatment Adherence and HIV Clinical Outcomes among People Living with HIV/AIDS and Depression Jon Mills University of North Carolina at Chapel Hill (UNC) Open
103 Development and Validation of a Multidimensional Index of Engagement in HIV Care Kristian Christopoulos and Mallory Johnson University of California San Francisco (UCSF) Open
105 The HIV Care Continuum: CD4 and Viral Load Measures as Proxies for Routine HIV Care Visits Kimberly Powers University of North Carolina at Chapel Hill (UNC) Open
106 Diminishing “Clinic Viral Load” in CNICS clinics in the U.S.: Socio-demographic and Therapeutic Correlations with Adherence Jane Simoni University of Washington (UW) Open
107 The CD4/CD8 ratio as a predictor of adverse outcomes in HIV-infected subjects under suppressive antiretroviral therapy and elite controllers Sergio Serrano-Villar University Hospital Ramón y Cajal- Madrid, Spain Open
108 Modeling Depression Treatment Strategies for Human Immunodeficiency Virus (HIV) Positive Patients Rongbing Xie University of Alabama at Birmingham (UAB) Open
109 Physical activity patterns and metabolic disease outcomes in people living with HIV Amanda Willig University of Alabama at Birmingham (UAB) Open
110 Projected Burden of Chronic Disease within the PLWH Population Julia Hood University of Washington (UW) Open
111 Impact of low-level HIV viremia on cancer risk Jennifer Lee University of North Carolina at Chapel Hill (UNC) Open
112 A statistical framework for integrated analysis of the HIV care cascade using CNICS data Hanna Lee Brown University Open
113 What to start: co-formulated versus individual tablets regimens in high-income countries Sarah Lodi Harvard University Closed
114 Self-management and quality of life in persons with HIV and diabetes, a comparison study. Julie Zuniga University of Texas Austin Open
115 Lipidomic Profiling in HIV patients newly initiating antiretroviral treatment Ryan Irvin University of Alabama at Birmingham (UAB) Open
116 Identification of Novel Metabolic Biomarkers for Predicting Cardiovascular Events in Persons Living with HIV Svati Shah Duke University Open
117 Supplement to Approved CP 103: Development and Validation of a Multidimensional Index of Engagement in HIV Care Kristina Christopoulos and Mallory Johnson University of California San Francisco (UCSF) Closed
118 Efavirenz and the risk of suicidality Angela Bengston University of North Carolina at Chapel Hill (UNC) Open
119 Age and Risk of HAART-Associated Nephrotoxicity: a Retrospective Cohort Study Jessie Torgersen Hospital of the University of Pennsylvania Open
121 Combined when to start analyses of the START trial, HIV-CAUSAL and CNICS Steve Cole University of North Carolina at Chapel Hill (UNC) Closed
122 At-Risk Alcohol Use and the Completion of Patient Reported Outcomes Jacquelin Rudolph University of North Carolina at Chapel Hill (UNC) Open
123 Examining causes of death among patients with HIV in the United States: methodologic tools and applications Jess Edwards University of North Carolina at Chapel Hill (UNC) Open
125 Durability of Contemporary Antiretroviral Regimens in Treatment Naïve Persons living with HIV Ellen Eaton University of Alabama at Birmingham (UAB) Open
126 Phylogeographic approach to determine the dynamics of HIV in circulating cellular reservoirs during ART failure and after re-suppression. Antoine Chaillon University of California San Diego (UCSD) Closed
127 Kidney Failure Risk Projection for the HIV-infected Living Kidney Donor Candidate Jayme Locke University of Alabama at Birmingham (UAB) Open
128 The Syndemics of Aging with HIV Maile Karris University of California San Diego (UCSD) Closed
129 Hemoglobin as a criterion to switch antiretroviral therapy in HIV-positive individuals Lauren Cain Harvard University Open
130 Comparative effectiveness of integrase-inhibitor-based regimens versus NNTRI- and boosted-PI-based regimens. Steve Cole University of North Carolina at Chapel Hill (UNC) Open
131 Patient-reported sexual risk behavior and viral suppression over time Julia Raifman Johns Hopkins Bloomberg School of Public Health Open
132 Comparing Duraility, Treatment Failure and Emergence of Resistance on Integrase Stand Transfer Inhibitor Treatment Regimens Among Treatment-Naïve and Treatment-Experienced Patients with HIV (UAB Protocol # X151228001) Heidi Crane University of Washington (UW) Open
134 The impact of substance use on health outcomes over time among persons living with HIV W. Scott Comulada University of California Los Angeles (UCLA) Closed
135 The Joint Effects and Plausible Interventions for ART and Statin Use on Mortality Jonathan Post University of North Carolina at Chapel Hill (UNC) Closed
136 Multi-level Social and Behavioral Determinants of Health and Missed HIV Healthcare Provider Visits April Pettit Vanderbilt University Open
137 Physical Activity and Symptom Distress in HIV+ Adults in the CNICS Database Allison Webel Case Western Reserve University Open
138 Statin use to prevent progression of liver disease among HIV infected individuals Bryan Lau Johns Hopkins University Open
139 Real World Effectiveness of Direct-Acting Antiviral Agents for Hepatitis C Infection Among HIV/HCV-Coinfected Patients Nina Kim University of Washington (UW) Open
140 Cigarette Smoking and HIV Treatment Outcomes Among MSM in Primary Care Conall O'Cleirigh Harvard University Open
141 Epidemiology of Heavily Treatment-Experienced (HTE) HIV Patients in the US Michael Saag and Ellen Eaton University of Alabama at Birmingham (UAB) Open
142 Development and Validation of Risk Prediction Model for End Stage Liver Disease and Hepatocellular Carcinoma in Persons living with HIV Nina Kim University of Washington (UW) Open
143 Evaluation of the efficacy, mechanism, and cost-effectiveness of Skills TO Manage Pain (STOMP), a novel group and peer-based behavioral intervention for chronic pain tailored to people living with HIV Jessie Merlin University of Alabama at Birmingham (UAB) Open
144 Rates and Predictors of Bacterial STI in Women with HIV Jodie Dionne-Odom University of Alabama at Birmingham (UAB) Open
145 Diabetes as a risk factor for tuberculosis in HIV positive individuals in the United States Kristina Bajema University of Washington (UW) Closed
146 A personalized approach to mental health in HIV Todd Fojo Johns Hopkins University Open
147 Epidemiology of HIV-related atrial fibrillation and associations with substance abuse Susan Heckbert University of Washington (UW) Open
148 Estimating the potential pool of HIV-infected deceased organ donors in the United States Jayme Locke University of Alabama at Birmingham (UAB) Open
149 Primary Infection Resource Consortium (PIRC) Susan Little University of California San Diego (UCSD) Closed
150 Patterns and Perceptions of e-Cigarettes and Vaporized Nicotine Among People Living with HIV Rob Fredericksen University of Washington (UW) Closed
151 Longitudinal HIV Care Trajectories and HIV Transmission Risk from the Time of HIV Care Entry in the CNICS Kimberly Powers University of North Carolina at Chapel Hill (UNC) Open
152 Condom-less sex behavior and health outcomes among HIV-infected patients in the PrEP era Rob Fredericksen University of Washington (UW) Open
153 Patient Usability and Acceptability of Electronic Patient-Reported Outcome Measures for Use in HIV Care Rob Fredericksen University of Washington (UW) Closed
154 Plasma IL-6 signaling biomarkers and cardiovascular disease in the CNICS cohort Lee Sulggi University of California San Francisco (UCSF) Closed
155 HIV/HCV Coinfection and Incidence of Extrahepatic Cancers Julia Marcus Harvard University Open
156 Predictive Analytics for Retention in HIV Care Jessica Ridgway University of Chicago Open
157 Understanding the effect of physical activity and dietary intake on the longitudinal symptom experience of HIV+ adults in the CNICS cohort Allison Webel and Amanda Willig Case Western Reserve University (CWRU) & University of Alabama at Birmingham (UAB) Open
157a Examining HIV-related Symptom Moderation of the Executive Function/Self-Management Process Nathaniel Schreiner Case Western Reserve University (CWRU) Open
158 Preparing for Long-Acting Injectable ART: Patient and Provider Perceptions, Preferences, and Shared Decision-Making David Wohl University of North Carolina at Chapel Hill (UNC) Open
159 Health Outcomes among Patients in HIV Care Reporting Intimate Partner Violence Rob Fredericksen University of Washington (UW) Open
160
Impact and Correlates of Sub-Optimal Social Support Among Patients in HIV Care Rob Fredericksen University of Washington (UW) Open
162 Viral suppression and sexual risk among people living with HIV: potential impact of risk compensation on HIV transmission Heather Pines University of California San Diego (UCSD) Open
163 Improving Kidney Health for African Americans with HIV through Optimal Antiretroviral Therapy Selection Ellen Eaton University of Alabama at Birmingham (UAB) Open
164 Role of medication assisted treatment on HIV treatment outcomes among opioid and stimulant users Javier Cepeda University of California San Diego (UCSD) Open
165 Effectiveness of second-line antiretroviral therapy Thibaut Davy-Mende University of North Carolina at Chapel Hill (UNC) Open
166 Genes, substance use, and HIV outcomes in people living with HIV across the US Heidi Crane University of Washington (UW) Open
167 Interventions to prevent cardiovascular disease among people living with HIV Alexander Breskin University of North Carolina at Chapel Hill (UNC) Closed
168 Characterization of Symptom Clusters Among People Living With HIV Disease Natalie Wilson University of California San Francisco (UCSF) Open
169 Effectiveness of a smoking cessation algorithm integrated into HIV primary care. Karen Cropsey University of Alabama at Birmingham (UAB) Closed
170 Determinants and Outcomes of Nicotine Metabolism in HIV Robert Gross University of Pennsylvania (UPENN) Open
171 Marijuana policy change impact on patterns of marijuana and other harmful substance use among people living with HIV: a mixed methods evaluation Andrew Hahn University of Washington (UW) Open
172 Prevalence and Risk Factors for Hepatitis Delta Infection Among a Cohort of HIV/Hepatitis B-Coinfected Patients in the United States Vincent Lo Re University of Pennsylvania (UPENN) Closed
173 Optimizing the Implementation of the U=U Strategy for HIV Prevention in Clinic Settings Curt Beckwith Brown University Open
174 Substance use and risk of stroke among people living with HIV Thomas Martin University of California San Diego (UCSD) Closed
176 Genetic predictors of adiposity-related traits including body mass index, lipoatrophy, lipohypertrophy and ART treatment-induced obesity among people living with HIV Sara Lindstroem University of Washington (UW) Open
178 Differences in substance use patterns among people living with HIV by geographic region Heidi Crane University of Washington (UW) Closed
179 Mental health, alcohol, and other substance use disorders Prevalence, co-occurrence and durability of symptoms; pharmacologic treatment initiation and retention; and impact of treatment on retention in HIV care and viral suppression Catherine Lesko Johns Hopkins University Open
180 Factors associated with Initiating Care for Vulnerable HIV-Infected Individuals with Substance Use Canada Parrish University of Washington (UW) Closed
181 Evaluating the impact of food insecurity on diabetes risk and treatment outcomes among adults with HIV+ in the PROSPER-HIV study Allison Webel and Amanda Willig Case Western Reserve University (CWRU) & University of Alabama at Birmingham (UAB) Open
182 Machine learning to identify persons at high-risk of disengaging from HIV care in the United States Sahar Saeed Washington University in St. Louis Open
184 Impact of FUT2 Genetic Variability on HIV-associated Inflammation. Mohamed Abdel-Mohsen Wistar Institute Open
185 Quality of life validation studies in CNICS Heidi Crane University of Washington (UW) Open
186 Impact of childhood abuse on health outcomes among patients living with HIV Rob Fredericksen University of Washington (UW) Open
187 Burden of Morbidity and Premature Mortality in patients with HIV-associated Malignancies
Guarav Goyal University of Alabama at Birmingham (UAB) Open
188 Antiretroviral Utilization in the Current Treatment Era (2018-2020) Jimmy Ma University of Washington (UW) Closed
190 Trauma and adherence: A lifecourse approach to understanding HIV in older adults Paul Nash University of Southern California Open
191 A cross sectional analysis of psychological stress, physical activity, and viral suppression as predictors of Cardiovascular Disease risk in older persons with HIV Crista Irwin Emory University Open
192 Mentoring Patient-Oriented Research on Advances to Optimize Engagement in HIV Care Katerina Christopoulos University of California San Francisco (UCSF) Open
193 Relationship between body fat and functional status among adults aging with HIV Vitor Oliveira Case Western Reserve University Closed
194 Deep Phenotyping of HIV-Related Heart Failure Matthew Feinstein Northwestern Open
195 Internalized HIV Stigma and Viral Suppression: Examining the Mediating and Moderating Roles of Social Support, Substance Use, and Depressive Symptoms Timothy Crawford Wright State University Boonshoft School of Medicine Open
196 Psychosocial Effects of HIV Nondisclosure Laws Among People Living with HIV Steve Safren University of Miami Open
197 Changes in weight after switching off of integrase strand transfer based regimens does the next regimen matter Jeff Yin University of California San Diego (UCSD) Closed
198 Determination of the Impact of Abnormal Glucose Levels on Progression to Frailty Among People Living with HIV Andrew Hahn University of Washington (UW) Open
200 Examining influences on physical activity behaviors and quality of life among adults living with HIV Sable Watson University of North Carolina at Chapel Hill (UNC) Open
201 Host Genetic Predictors of Vascular Complications: A CNICS Mendelian Randomization Study Sulggi Lee University of Chicago Closed
204 Cardiometabolic Disease Among Frailty Clusters in Adults Aging with HIV Raymond Jones University of Alabama at Birmingham (UAB) Open
205 Understanding Racial and the Social Determinants of Disparities in
Depression and Non-Communicable Disease Outcomes in Adults Living with
HIVAima Ahonkhai Vanderbilt University Open
206 Effect of Internalized HIV Stigma on Cardiovascular Disease Risk in Women Living with HIV Jess Sherman Ohio State University Open
207 Impact of depression and HIV symptoms on glycemic outcomes (A1c, BG) among patients living with HIV and type 2 diabetes. Veronica Brady University of Texas Health Science Center at Houston Open
208 Role of integrase strand transfer based regimens in people with HIV and hypertension Mohammed Siddiqui University of Alabama at Birmingham (UAB) Open
209 Internalized HIV Stigma, Age and Gender related outcomes among people with HIV (HIV StAGe Outcomes) Lydia Drumright University of Washington (UW) Open
211 Identifying genetic contributors for cardiovascular disease with people with HIV-infection Nicole Armstrong University of Alabama at Birmingham (UAB) Open
212 Aging, Depressive Symptoms, Antidepressant Effectiveness, and Incidence of Stroke among People with HIV Jimmy Ma University of Washington (UW) Open
213 Alcohol Research Consortium in HIV – Epidemiological Research Arm from P01 AA029544 Heidi Crane University of Washington (UW) Open
214 Re-demonstrating the clinical relevance of retention in care: A longitudinal multisite analysis of two cohorts Emma Kay Birmingham AIDS Outreach (BAO) Open
215 Characterization and Clustering of Symptoms in People with HIV
Tru Cao University of Texas Health Science Center at Houston
Open
216 Type 1 Hybrid Effectiveness-Implementation Trial of a Digital Therapeutic for Smoking Cessation Tailored to Persons Living with HIV Roger Villardaga Wake Forest University
University of BuffaloOpen
219 Renewal application: Impact of Physical Activity Routines and Dietary Intake on the Longitudinal Symptom Experience of the people living with HIV (PROSPER-HIV 2) Allison Webel and Mandy Willig University of Alabama at Birmingham (UAB) Open
220 Evaluating Risk Factors and Prevalence of Hepatitis C Viremia among People with HIV in the Direct Acting Antiviral Era
Jimmy Ma University of Washington (UW) Open
221 Antibiotics for Treatment of Methamphetamine Use Disorder Among People Living with HIV Aurelio Galli University of Alabama at Birmingham (UAB) Open
222 Evaluating the impact of genital STI diagnosis on incidence of HCV infection in PWH Yotam Arens University of Pennsylvania (UPENN) Open
223 Behavioral health characteristics related to adherence in PLWH Cristina Lopez Medical University of South Carolina (Charleston SC) Open
224 Eicosanoids as Novel Inflammatory Mediators of CVD in Men and Women with HIV Claudia Martinez University of Miami Open
225 Innovative Computational Tools and Best Practice Recommendations for Analyzing HIV-related Count Outcomes
David Huh University of Washington (UW) Open
226 Malignancy incidence and phenotype following acute cardiovascular events in CNICS Matthew Feinstein Northwestern Closed
227 Elucidating Genetic Risk Factors for AKI and AKI-related Outcomes among People with HIV Molly Fisher Albert Einstein College of Medicine, Montefiore Medical Center Open
228 Addressing Barriers to the Comprehensive Use of Statins in people with HIV: the ABACUS-HIV study Thibaut Davy-Mendez University of North Carolina at Chapel Hill (UNC) Open
229 Impact of New Antidiabetic Medications Among People with HIV Sherif Eltonsy University of Manitoba Open
230 Associations Between Chronic Kidney Disease (CKD) and Substance Use, Hypertension, Insomnia, and Diabetes Among PWH
Chris Delaney University of Washington (UW) Open
231 Exploration of Depressive Symptoms in the Diagnosis of Type 2 Diabetes in People Living with HIV Shelagh Mulvaney Vanderbilt University Open
232 Frailty and frailty transitions in aging persons with HIV: are they associated with serum miRNA profiles? Lee D Chaves University of Kansas Medical Center
Open
233 Syndemic Trajectories among Gay, Bisexual, and Other Men Who Have Sex with Men living with HIV in the U.S.
Pablo Valente University of Connecticut (UConn) Open
234 Prediction of Hepatocellular Carcinoma Risk in HIV/HBV Coinfected Individuals of Black/African Ethnicity and Other Populations in the CNICS Cohort using the PAGE-B and mPAGE-B Scores George Yendewa Case Western Reserve University Open
235 Enhance Social Support for Black Women with HIV Using Technology Crystal Chapman Lambert University of Alabama at Birmingham (UAB) Open
236 Lung cancer prediction and outcomes model for people living with HIV (R01 proposal) Kristina Crother University of Washington (UW) Open
237 Exploring the Potential for Psychedelics to Reduce HIV Infections and Improve Health and Wellbeing in Gay, Bisexual, and Other Cisgender Men Who Have Sex with Men in the US Nic Carlisle University of Alabama at Birmingham (UAB) Open
238 Association of 1991 birth-dose Hepatitis B Virus (HBV) vaccination policy in the United States and HBV prevalence among PWH enrolled in HIV care Tarfa Verinumbe Johns Hopkins University Open
239 HIV, Comorbidities, and Behavioral Health Outcomes by Neighborhood Physical and Social Environments through Geocoded Variables Carolyn Fahey University of Washington (UW) Open
240 Ubiquitin D (UBD) variants and CKD outcomes in persons with HIV Michael Ross Albert Einstein College of Medicine Open
241 Centering HIV Stigma in Clinical Conversations to increase Alcohol Treatment Uptake (CHAT) Elizabeth Austin University of Washington (UW) Open
242 Intersecting Identities Cannabis Use, HIV Stigma, and Associations with Health Outcomes Nathaniel Fox University of California San Diego (UCSD) Open
243 Correlates, outcomes, and determinants of tobacco and cannabis co-use among people with HIV Rebecca Ashare State University of New York at Buffalo Open
244 Biopsychosocial, physical function, and physical activity correlates in older adults living with HIV and co-occurring chronic pain Taylor Taylor University of Alabama at Birmingham (UAB) Open
245 Housing stability and clinical care outcomes among people with HIV in the CNICS cohort Bridget Whitney University of Washington (UW) Open
248 Characterizing racial and demographic disparities in substance use treatment uptake and subsequent treatment outcomes among people with HIV in the CNICS cohort Rob Fredericksen University of Washington (UW) Open
249 Does Lipoprotein(a) improve CVD risk prediction in people with HIV? Thibaut Davy-Mendez University of North Carolina at Chapel Hill (UNC) Open
252 Hepatitis B Outcomes Among US Adults with HIV Treated with Tenofovir-Sparing Antiretroviral Therapy Regimens in the Center for AIDS Research Network of Integrated Systems Database Grace Haser University of California San Francisco (UCSF) Open
